Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TOTAL RECEIVABLES
Total Receivables HALO - Halozyme Therapeutics, Inc.
234 M
LAST VALUE
60.45%
2 YEAR CAGR
50.83%
5 YEAR CAGR
38.38%
10 YEAR CAGR